Quest diagnostics reports first quarter 2023 financial results; updates guidance for full year 2023

First quarter revenues of $2.33 billion, down 10.7% from 2022 first quarter reported diluted earnings per share ("eps") of $1.78, down 39.0% from 2022; and adjusted diluted eps of $2.04, down 36.6% from 2022 first quarter base business revenues of $2.21 billion, up 10.0% from 2022 full year 2023 revenues now expected to be between $8.93 billion and $9.08 billion; reported diluted eps now expected to be between $7.52 and $8.02; and adjusted diluted eps expected to be between $8.45 and $8.95 secaucus, n.j. , april 27, 2023 /prnewswire/ -- quest diagnostics incorporated (nyse: dgx), the world's leading provider of diagnostic information services, announced today financial results for the first quarter ended march 31, 2023.
DGX Ratings Summary
DGX Quant Ranking